INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SM
Sorrells Julie MarieV.P. & CORPORATE CONTROLLER
AMCRAmcor plc
Option exercise
M—
1,047 sh
Aug 28, 2026Aug 28, 2026
Page 435 of 1693
← PrevNext →
traded Aug 28, 2026
+0d
SEC Form 4

Evidence

9
KJ
Kemly Thomas J.Director, President & CEO
CLBKColumbia Financial, Inc./MD/
Grant or award
A$7,683
661 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
HE
Heinzelman Kate ElizabethGeneral Counsel
CGCarlyle Group Inc.
Grant or award
A—
78 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
SD
Sonenreich Steven DDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
7,671 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
HT
Hagale James TysonPresident - Leggett & Platt
SGISOMNIGROUP INTERNATIONAL INC.
Grant or award
A—
4,992 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
WH
Warrington Kenneth Howard JrDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
5,094 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
RE
Randall Elizabeth E.Director
CLBKColumbia Financial, Inc./MD/
Grant or award
A$2,459
212 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
Schwartz Harvey MDirector, Chief Executive Officer
CGCarlyle Group Inc.
Grant or award
A—
19.2K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
SM
Stringham Brent MichaelChief Financial Officer
LTRXLANTRONIX INC
Grant or award
A—
38.4K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
GL
Grindstaff LyndaDirector
OFGOFG BANCORP
Tax withholding
F$259
5 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
AS
Awsare SaleelDirector, President & CEO
LTRXLANTRONIX INC
Grant or award
A—
82.4K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
MM
Morrell MarthaCHIEF MEDICAL OFFICER
NPCENeuroPace Inc
Tax withholding
F$5,059
358 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
SK
Schlesinger Allyson KatzSEVP&Head of Consumer Banking
CLBKColumbia Financial, Inc./MD/
Grant or award
A$511
44 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
SJ
Scheiwer Mark JEVP, CFO & CAO
SMGSCOTTS MIRACLE-GRO CO
Grant or award
A$750
12 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
ME
Miller Kristine EDirector
GROVGrove Collaborative Holdings, Inc.
Grant or award
A—
64.2K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
HT
Hagale James TysonPresident - Leggett & Platt
SGISOMNIGROUP INTERNATIONAL INC.
Grant or award
A—
1,109 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
SD
Sonenreich Steven DDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
7,671 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
PB
Prabhu Manesh BalachandranEVP & CIO
CLBKColumbia Financial, Inc./MD/
Grant or award
A$112
10 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
SM
Sorrells Julie MarieV.P. & CORPORATE CONTROLLER
AMCRAmcor plc
Tax withholding
F—
350 sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

9
HT
Hagale James TysonPresident - Leggett & Platt
SGISOMNIGROUP INTERNATIONAL INC.
Grant or award
A—
4,992 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
KO
Kraft Robert O.Director
MEDPMedpace Holdings, Inc.
Option exercise
M—
3,858 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
SM
Sorrells Julie MarieV.P. & CORPORATE CONTROLLER
AMCRAmcor plc
Tax withholding
F—
272 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
LE
Lewis Oliver Edward JrSEVP & Head Commercial Banking
CLBKColumbia Financial, Inc./MD/
Grant or award
A$540
46 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
MS
Mertens SteveChief Technology Officer
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Grant or award
A—
15.0K sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

9
JJ
Johns Emily J.Chief Administrative Officer
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Grant or award
A—
12.5K sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

9
SL
Sorrentini LucyDirector
CLBKColumbia Financial, Inc./MD/
Grant or award
A$845
73 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
HT
Hagale James TysonPresident - Leggett & Platt
SGISOMNIGROUP INTERNATIONAL INC.
Grant or award
A—
6,148 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
HT
Hagale James TysonPresident - Leggett & Platt
SGISOMNIGROUP INTERNATIONAL INC.
Grant or award
A—
10.8K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
NJ
Nedelman JeffreyCo-President
CGCarlyle Group Inc.
Grant or award
A—
6,615 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
GL
Grindstaff LyndaDirector
OFGOFG BANCORP
Option exercise
M—
50 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Option exercise
M$223K
27.5K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
CT
Curran TerrieDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M—
27.1K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
KJ
Kemly Thomas J.Director, President & CEO
CLBKColumbia Financial, Inc./MD/
Grant or award
A$4,555
392 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
HT
Hagale James TysonPresident - Leggett & Platt
SGISOMNIGROUP INTERNATIONAL INC.
Grant or award
A—
10.8K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
PJ
Plouffe JustinChief Financial Officer
CGCarlyle Group Inc.
Grant or award
A—
3,769 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
SS
Suarez Gonzalez SusanaEX. VP & CHIEF HUMAN RESOURCES
AMCRAmcor plc
Grant or award
A—
6,633 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
KJ
Klimowich JohnSEVP & Chief Risk Officer
CLBKColumbia Financial, Inc./MD/
Grant or award
A$453
39 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
KJ
Klimowich JohnSEVP & Chief Risk Officer
CLBKColumbia Financial, Inc./MD/
Grant or award
A$1,023
88 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
JD
Jenkins Mark DavidCo-President
CGCarlyle Group Inc.
Grant or award
A—
6,264 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
GM
Gurusamy MathiChief Product & Strategy Ofcr
LTRXLANTRONIX INC
Grant or award
A—
32.8K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence